Systemic precipitation of underlying arterial thrombosis in a COVID-19 infected patients.

Abstract

Pandemic COVID-19 has brought forward a wide array of organ-specific and systemic disorders, one such being raised susceptibility towards development of systemic coagulopathies (venous, arterial or microvascular thrombi), which often contributes to the high incidence of thrombotic complications, such as deep venous thrombosis, pulmonary embolism, associated with common thrombotic arterial complications (eg, limb ischemia, ischemic stroke, myocardial infarction) in critically ill patients. A similar picture is also seems to have been painted in our cases discussed below, whereby underlying SARS CoV 2 infection has predisposed patients to hypercoagulability-related disorders including thrombosis and other fatal vascular events. Making the start of prompt antithrombosis prophylaxis are necessary to ensure better recovery in both the pre-operative and post operative period and regular re-evaluation of basic investigations (PT-INR, aPTT, D-Dimer) to ensure timely action for any change, enabling optimal patient care and recovery.